Numerous inventive platforms and engineering approaches have created the next-generation of bispecific antibodies with improved functionality, selectivity, and specificity. Many of these are advancing to the clinic and challenges in targeting and safety have been overcome. Explore one of the most exciting areas in biologics and discover what the newest platforms and engineering approaches are that promise an increasingly diverse array of successful constructs that can achieve unprecedented efficacy.